(Total Views: 289)
Posted On: 01/29/2020 4:46:41 PM
Post# of 8403
BIEL Movin On Up to the Nines, Congratulations Shareholders!!
53 million shares in Buys
8 million shares in Sells
Bid Price …. .0008
Ask Price …. .0009
BIEL is closing in on 3 Major Events:
* FDA OTC Full Body Musculoskeletal Clearance - This is the Clearance BIEL has been working 19 years to get allowing ActiPatch to be used anywhere on the body, the 510k is in 'Interactive Review' which is the last phase before approval, this Clearance Triggers Major Deals
* Dr Scholl's Licensing Deal - Yellow Wood Partners, Dr Scholl's parent company, had a BOD Meeting on 1/23 to decide on the BIEL Deal
* Global Orthopedic OEM Partnership - The company has yet to be named but it is big as the 2020 revenue would be in excess of $2 million for BIEL, the last Update placed the Contract in a legal department review with the Orthopedic company with completion scheduled for January
53 million shares in Buys
8 million shares in Sells
Bid Price …. .0008
Ask Price …. .0009
BIEL is closing in on 3 Major Events:
* FDA OTC Full Body Musculoskeletal Clearance - This is the Clearance BIEL has been working 19 years to get allowing ActiPatch to be used anywhere on the body, the 510k is in 'Interactive Review' which is the last phase before approval, this Clearance Triggers Major Deals
* Dr Scholl's Licensing Deal - Yellow Wood Partners, Dr Scholl's parent company, had a BOD Meeting on 1/23 to decide on the BIEL Deal
* Global Orthopedic OEM Partnership - The company has yet to be named but it is big as the 2020 revenue would be in excess of $2 million for BIEL, the last Update placed the Contract in a legal department review with the Orthopedic company with completion scheduled for January
(0)
(0)
